A Survey of the Ce-Tubulin Gene Family in Chicken: Unexpected Sequence Heterogeneity in the Polypeptides Encoded by Five Expressed Genes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Identification of Differentially Expressed Genes in Human Bladder Cancer Through Genome-Wide Gene Expression Profiling
521-531 24/7/06 18:28 Page 521 ONCOLOGY REPORTS 16: 521-531, 2006 521 Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling KAZUMORI KAWAKAMI1,3, HIDEKI ENOKIDA1, TOKUSHI TACHIWADA1, TAKENARI GOTANDA1, KENGO TSUNEYOSHI1, HIROYUKI KUBO1, KENRYU NISHIYAMA1, MASAKI TAKIGUCHI2, MASAYUKI NAKAGAWA1 and NAOHIKO SEKI3 1Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520; Departments of 2Biochemistry and Genetics, and 3Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Received February 15, 2006; Accepted April 27, 2006 Abstract. Large-scale gene expression profiling is an effective CKS2 gene not only as a potential biomarker for diagnosing, strategy for understanding the progression of bladder cancer but also for staging human BC. This is the first report (BC). The aim of this study was to identify genes that are demonstrating that CKS2 expression is strongly correlated expressed differently in the course of BC progression and to with the progression of human BC. establish new biomarkers for BC. Specimens from 21 patients with pathologically confirmed superficial (n=10) or Introduction invasive (n=11) BC and 4 normal bladder samples were studied; samples from 14 of the 21 BC samples were subjected Bladder cancer (BC) is among the 5 most common to microarray analysis. The validity of the microarray results malignancies worldwide, and the 2nd most common tumor of was verified by real-time RT-PCR. Of the 136 up-regulated the genitourinary tract and the 2nd most common cause of genes we detected, 21 were present in all 14 BCs examined death in patients with cancer of the urinary tract (1-7). -
Ultraconserved Elements Are Associated with Homeostatic Control of Splicing Regulators by Alternative Splicing and Nonsense-Mediated Decay
Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay Julie Z. Ni,1 Leslie Grate,1 John Paul Donohue,1 Christine Preston,2 Naomi Nobida,2 Georgeann O’Brien,2 Lily Shiue,1 Tyson A. Clark,3 John E. Blume,3 and Manuel Ares Jr.1,2,4 1Center for Molecular Biology of RNA and Department of Molecular, Cell, and Developmental Biology, University of California at Santa Cruz, Santa Cruz, California 95064, USA; 2Hughes Undergraduate Research Laboratory, University of California at Santa Cruz, Santa Cruz, California 95064, USA; 3Affymetrix, Inc., Santa Clara, California 95051, USA Many alternative splicing events create RNAs with premature stop codons, suggesting that alternative splicing coupled with nonsense-mediated decay (AS-NMD) may regulate gene expression post-transcriptionally. We tested this idea in mice by blocking NMD and measuring changes in isoform representation using splicing-sensitive microarrays. We found a striking class of highly conserved stop codon-containing exons whose inclusion renders the transcript sensitive to NMD. A genomic search for additional examples identified >50 such exons in genes with a variety of functions. These exons are unusually frequent in genes that encode splicing activators and are unexpectedly enriched in the so-called “ultraconserved” elements in the mammalian lineage. Further analysis show that NMD of mRNAs for splicing activators such as SR proteins is triggered by splicing activation events, whereas NMD of the mRNAs for negatively acting hnRNP proteins is triggered by splicing repression, a polarity consistent with widespread homeostatic control of splicing regulator gene expression. -
Novel Potential ALL Low-Risk Markers Revealed by Gene
Leukemia (2003) 17, 1891–1900 & 2003 Nature Publishing Group All rights reserved 0887-6924/03 $25.00 www.nature.com/leu BIO-TECHNICAL METHODS (BTS) Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH–CCS–PCR J Qiu1,5, P Gunaratne2,5, LE Peterson3, D Khurana2, N Walsham2, H Loulseged2, RJ Karni1, E Roussel4, RA Gibbs2, JF Margolin1,6 and MC Gingras1,6 1Texas Children’s Cancer Center and Department of Pediatrics; 2Human Genome Sequencing Center, Department of Molecular and Human Genetics; 3Department of Internal Medicine; 1,2,3 are all departments of Baylor College of Medicine, Baylor College of Medicine, Houston, TX, USA; and 4BioTher Corporation, Houston, TX, USA The current systems of risk grouping in pediatric acute t(1;19), BCR-ABL t(9;22), and MLL-AF4 t(4;11).1 These chromo- lymphoblastic leukemia (ALL) fail to predict therapeutic suc- somal modifications and other clinical findings such as age and cess in 10–35% of patients. To identify better predictive markers of clinical behavior in ALL, we have developed an integrated initial white blood cell count (WBC) define pediatric ALL approach for gene expression profiling that couples suppres- subgroups and are used as diagnostic and prognostic markers to sion subtractive hybridization, concatenated cDNA sequencing, assign specific risk-adjusted therapies. For instance, 1.0 to 9.9- and reverse transcriptase real-time quantitative PCR. Using this year-old patients with none of the determinant chromosomal approach, a total of 600 differentially expressed genes were translocation (NDCT) mentioned above but with a WBC higher identified between t(4;11) ALL and pre-B ALL with no determi- than 50 000 cells/ml are associated with higher risk group.2 nant chromosomal translocation. -
Novel Targets of Apparently Idiopathic Male Infertility
International Journal of Molecular Sciences Review Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility Rossella Cannarella * , Rosita A. Condorelli , Laura M. Mongioì, Sandro La Vignera * and Aldo E. Calogero Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy; [email protected] (R.A.C.); [email protected] (L.M.M.); [email protected] (A.E.C.) * Correspondence: [email protected] (R.C.); [email protected] (S.L.V.) Received: 8 February 2020; Accepted: 2 March 2020; Published: 3 March 2020 Abstract: Male infertility affects half of infertile couples and, currently, a relevant percentage of cases of male infertility is considered as idiopathic. Although the male contribution to human fertilization has traditionally been restricted to sperm DNA, current evidence suggest that a relevant number of sperm transcripts and proteins are involved in acrosome reactions, sperm-oocyte fusion and, once released into the oocyte, embryo growth and development. The aim of this review is to provide updated and comprehensive insight into the molecular biology of spermatogenesis, including evidence on spermatogenetic failure and underlining the role of the sperm-carried molecular factors involved in oocyte fertilization and embryo growth. This represents the first step in the identification of new possible diagnostic and, possibly, therapeutic markers in the field of apparently idiopathic male infertility. Keywords: spermatogenetic failure; embryo growth; male infertility; spermatogenesis; recurrent pregnancy loss; sperm proteome; DNA fragmentation; sperm transcriptome 1. Introduction Infertility is a widespread condition in industrialized countries, affecting up to 15% of couples of childbearing age [1]. It is defined as the inability to achieve conception after 1–2 years of unprotected sexual intercourse [2]. -
TCP1 Theta (CCT8) (NM 006585) Human Tagged ORF Clone Product Data
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC210044 TCP1 theta (CCT8) (NM_006585) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: TCP1 theta (CCT8) (NM_006585) Human Tagged ORF Clone Tag: Myc-DDK Symbol: CCT8 Synonyms: C21orf112; Cctq; D21S246; PRED71 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 5 TCP1 theta (CCT8) (NM_006585) Human Tagged ORF Clone – RC210044 ORF Nucleotide >RC210044 ORF sequence Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGGCGCTTCACGTTCCCAAGGCTCCGGGCTTTGCCCAGATGCTCAAGGAGGGAGCGAAACACTTTTCAG GATTAGAAGAGGCTGTGTATAGAAACATACAAGCTTGCAAGGAGCTTGCCCAAACCACTCGTACAGCATA TGGACCAAATGGAATGAACAAAATGGTTATCAACCACTTGGAGAAGTTGTTTGTGACAAACGATGCAGCA ACTATTTTAAGAGAACTAGAAGTACAGCATCCTGCTGCAAAAATGATTGTAATGGCTTCTCATATGCAAG AGCAAGAAGTTGGAGATGGCACAAACTTTGTTCTGGTATTTGCTGGAGCTCTCCTGGAATTAGCTGAAGA ACTTCTGAGGATTGGCCTGTCAGTTTCAGAGGTCATAGAAGGTTATGAAATAGCCTGCAGAAAAGCTCAT GAGATTCTTCCTAATTTGGTATGTTGTTCTGCAAAAAACCTTCGAGATATTGATGAAGTCTCATCTCTAC TTCGTACCTCCATAATGAGTAAACAATATGGTAATGAAGTATTTCTGGCCAAGCTTATTGCTCAGGCATG CGTATCTATTTTTCCTGATTCCGGCCATTTCAATGTTGATAACATCAGAGTTTGTAAAATTCTGGGCTCT -
CA8 (NM 004056) Human Tagged ORF Clone – RG210228 | Origene
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RG210228 CA8 (NM_004056) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: CA8 (NM_004056) Human Tagged ORF Clone Tag: TurboGFP Symbol: CA8 Synonyms: CA-RP; CA-VIII; CALS; CAMRQ3; CARP Vector: pCMV6-AC-GFP (PS100010) E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: Neomycin ORF Nucleotide >RG210228 representing NM_004056 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGGCGGACCTGAGCTTCATCGAAGATACCGTCGCCTTCCCCGAGAAGGAAGAGGATGAGGAGGAAGAAG AGGAGGGTGTGGAGTGGGGCTACGAGGAAGGTGTTGAGTGGGGTCTGGTGTTTCCTGATGCTAATGGGGA ATACCAGTCTCCTATTAACCTAAACTCAAGAGAGGCTAGGTATGACCCCTCGCTGTTGGATGTCCGCCTC TCCCCAAATTATGTGGTGTGCCGAGACTGTGAAGTCACCAATGATGGACATACCATTCAGGTTATCCTGA AGTCAAAATCAGTTCTTTCGGGAGGACCATTGCCTCAAGGGCATGAATTTGAACTGTACGAAGTGAGATT TCACTGGGGAAGAGAAAACCAGCGTGGTTCTGAGCACACGGTTAATTTCAAAGCTTTTCCCATGGAGCTC CATCTGATCCACTGGAACTCCACTCTGTTTGGCAGCATTGATGAGGCTGTGGGGAAGCCGCACGGAATCG CCATCATTGCTCTGTTTGTTCAGATAGGAAAGGAACATGTTGGCTTGAAGGCTGTGACTGAAATCCTCCA AGATATTCAGTATAAGGGGAAGTCCAAAACAATACCTTGCTTTAATCCTAACACTTTATTACCAGACCCT CTGCTGCGGGATTACTGGGTGTATGAAGGCTCTCTCACCATCCCACCTTGCAGTGAAGGTGTCACCTGGA TATTATTCCGATACCCTTTAACTATATCCCAGCTACAGATAGAAGAATTTCGAAGGCTGAGGACACATGT TAAGGGGGCAGAACTTGTGGAAGGCTGTGATGGGATTTTGGGAGACAACTTTCGGCCCACTCAGCCTCTT AGTGACAGAGTCATTAGAGCTGCATTTCAG -
Investigating the Effects of Human Carbonic Anhydrase 1 Expression
Investigating the effects of human Carbonic Anhydrase 1 expression in mammalian cells Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Xiaochen Liu, BSc, MSc January 2016 ABSTRACT Amyotrophic Lateral Sclerosis (ALS) is one of the most common motor neuron diseases with a crude annual incidence rate of ~2 cases per 100,000 in European countries, Japan, United States and Canada. The role of Carbonic Anhydrase 1 (CA1) in ALS pathogenesis is completely unknown. Previous unpublished results from Dr. Jian Liu have shown in the spinal cords of patients with sporadic amyotrophic lateral sclerosis (SALS) there is a significant increased expression of CA1 proteins. The purpose of this study is to examine the effect of CA1 expression in mammalian cells, specifically, whether CA1 expression will affect cellular viability and induce apoptosis. To further understand whether such effect is dependent upon CA1 enzymatic activity, three CA1 mutants (Thr199Val, Glu106Ile and Glu106Gln) were generated using two- step PCR mutagenesis. Also, a fluorescence-based assay using the pH-sensitive fluorophore Pyranine (8-hydroxypyrene-1,3,6-trisulfonic acid) to measure the anhydrase activity was developed. The assay has been able to circumvent the requirement of the specialized equipment by utilizing a sensitive and fast microplate reader and demonstrated that three - mutants are enzymatically inactive under the physiologically relevant HCO3 dehydration reaction which has not been tested before by others. The data show that transient expression of CA1 in Human Embryonic Kidney 293 (HEK293), African Green Monkey Kidney Fibroblast (COS7) and Human Breast Adenocarcinoma (MCF7) cell lines did not induce significant changes to the cell viability at 36hrs using the Water Soluble Tetrazolium-8 (WST8) assay. -
CA8 Rabbit Pab
Leader in Biomolecular Solutions for Life Science CA8 Rabbit pAb Catalog No.: A7544 Basic Information Background Catalog No. The protein encoded by this gene was initially named CA-related protein because of A7544 sequence similarity to other known carbonic anhydrase genes. However, the gene product lacks carbonic anhydrase activity (i.e., the reversible hydration of carbon Observed MW dioxide). The gene product continues to carry a carbonic anhydrase designation based 33kDa on clear sequence identity to other members of the carbonic anhydrase gene family. The absence of CA8 gene transcription in the cerebellum of the lurcher mutant in mice with a Calculated MW neurologic defect suggests an important role for this acatalytic form. Mutations in this 32kDa gene are associated with cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CMARQ3). Polymorphisms in this gene are associated with osteoporosis, Category and overexpression of this gene in osteosarcoma cells suggests an oncogenic role. Alternative splicing results in multiple transcript variants. Primary antibody Applications WB, IHC Cross-Reactivity Human, Mouse Recommended Dilutions Immunogen Information WB 1:500 - 1:2000 Gene ID Swiss Prot 767 P35219 IHC 1:50 - 1:200 Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-290 of human CA8 (NP_004047.3). Synonyms CA8;CA-RP;CA-VIII;CALS;CAMRQ3;CARP Contact Product Information www.abclonal.com Source Isotype Purification Rabbit IgG Affinity purification Storage Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide,50% glycerol,pH7.3. Validation Data Western blot analysis of extracts of various cell lines, using CA8 antibody (A7544) at 1:1000 dilution. -
Human Carbonic Anhydrase IX Quantikine
Quantikine® ELISA Human Carbonic Anhydrase IX Immunoassay Catalog Number DCA900 For the quantitative determination of human Carbonic Anhydrase IX (CA9) concentrations in cell culture supernates, serum, plasma, and urine. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures. TABLE OF CONTENTS SECTION PAGE INTRODUCTION ....................................................................................................................................................................1 PRINCIPLE OF THE ASSAY ..................................................................................................................................................2 LIMITATIONS OF THE PROCEDURE ................................................................................................................................2 TECHNICAL HINTS ................................................................................................................................................................2 MATERIALS PROVIDED & STORAGE CONDITIONS ..................................................................................................3 OTHER SUPPLIES REQUIRED ............................................................................................................................................3 PRECAUTIONS ........................................................................................................................................................................4 -
Recombinant Human Carbonic Anhydrase VIII/CA8 Protein Catalog Number: ATGP1388
Recombinant human Carbonic Anhydrase VIII/CA8 protein Catalog Number: ATGP1388 PRODUCT INPORMATION Expression system E.coli Domain 1-290aa UniProt No. P35219 NCBI Accession No. NP_004047 Alternative Names Carbonic anhydrase-related protein, CA-VIII, CALS, CAMRQ3, CARP PRODUCT SPECIFICATION Molecular Weight 35.5 kDa (314aa) confirmed by MALDI-TOF (Molecular weight on SDS-PAGE will appear higher) Concentration 1mg/ml (determined by Bradford assay) Formulation Liquid in. 20mM Tris-HCl buffer (pH 8.0) containing 20% glycerol, 1mM DTT Purity > 90% by SDS-PAGE Tag His-Tag Application SDS-PAGE Storage Condition Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles. BACKGROUND Description CA8 was initially named CA-related protein because of sequence similarity to other known carbonic anhydrase genes. However, this protein lacks carbonic anhydrase activity (i. e., the reversible hydration of carbon dioxide). It continues to carry a carbonic anhydrase designation based on clear sequence identity to other members of the carbonic anhydrase gene family. Defects in CA8 are the cause of cerebellar ataxia mental retardation and dysequilibrium syndrome type 3 (CMARQ3). Recombinant human CA8 protein fused to His-tag at N-terminus, was expressed in E. coli and purified by using conventional chromatography. 1 Recombinant human Carbonic Anhydrase VIII/CA8 protein Catalog Number: ATGP1388 Amino acid Sequence MGSSHHHHHH SSGLVPRGSH MGSHMADLSF IEDTVAFPEK EEDEEEEEEG VEWGYEEGVE WGLVFPDANG EYQSPINLNS REARYDPSLL DVRLSPNYVV CRDCEVTNDG HTIQVILKSK SVLSGGPLPQ GHEFELYEVR FHWGRENQRG SEHTVNFKAF PMELHLIHWN STLFGSIDEA VGKPHGIAII ALFVQIGKEH VGLKAVTEIL QDIQYKGKSK TIPCFNPNTL LPDPLLRDYW VYEGSLTIPP CSEGVTWILF RYPLTISQLQ IEEFRRLRTH VKGAELVEGC DGILGDNFRP TQPLSDRVIR AAFQ General References Turkmen S., et al. -
Identification of Five Putative Yeast RNA Helicase Genes
Proc. Nati. Acad. Sci. USA Vol. 87, pp. 1571-1575, February 1990 Biochemistry Identification of five putative yeast RNA helicase genes (gene family/degenerate oligonucleotides/polymerase chain reaction) TIEN-HsIEN CHANG, JAIME ARENAS, AND JOHN ABELSON Division of Biology 147-75, California Institute of Technology, Pasadena, CA 91125 Contributed by John Abelson, December 5, 1989 ABSTRACT The RNA helicase gene family encodes a characterized Drosophila gene vasa (7); yeast genes TIFI, group of eight homologous proteins that share regions of TIF2, and MSSJ16 (8, 9); as well as mouse PLIO gene (10). sequence similarity. This group of evolutionarily conserved Based on the amino acid sequence alignments of these pro- proteins presumably all utilize ATP (or some other nucleoside teins, an additional gene family, the RNA helicase gene family, triphosphate)' as an energy source for unwinding double- consisting of both established and putative RNA helicase stranded RNA. Members of this family have been implicated in genes, was defined (11). Although the sequence conservation a variety of physiological functions in organisms ranging from is spread out over a stretch of 420 amino acids, several Escherichia coli to human, such as translation initiation, mito- sequence elements are especially striking. The sequence D X4 chondrial mRNA splicing, ribosomal assembly, and germinal A X4 G K T, found in all eight proteins, is typical for the A line cell differentiation. We have applied polymerase chain motif of ATP binding proteins (12-14). The D E A D reaction technology to search for additional members of the box, (V/I) L D E A D X2 L, on the other hand, represents a RNA helicase family in the yeast Saccharomyces cerevisiae. -
Carbonic Anhydrase VIII (CA8) Is a Differentially Expressed Gene in Brain Metastatic Human Breast Cancer
Carbonic anhydrase VIII (CA8) is a differentially expressed gene in brain metastatic human breast cancer. Shahan Mamoor, MS1 1 [email protected] East Islip, NY USA 1-3 Metastasis to the brain is a clinical problem in patients with breast cancer . We mined published 4,5 microarray data to compare primary and metastatic tumor transcriptomes for the discovery of genes associated with brain metastasis in humans with metastatic breast cancer. We found that carbonic anhydrase VIII, encoded by CA8, was among the genes whose expression was most different in the brain metastases of patients with metastatic breast cancer as compared to primary tumors of the breast. CA8 mRNA was present at increased quantities in brain metastatic tissues as compared to primary tumors of the breast. Importantly, expression of CA8 in primary tumors was significantly correlated with patient distant metastasis-free survival. Modulation of CA8 expression may be relevant to the biology by which tumor cells metastasize from the breast to the brain in humans with metastatic breast cancer. Keywords: breast cancer, metastasis, brain metastases, central nervous system metastases, carbonic anhydrase 8, CA8, systems biology of breast cancer, targeted therapeutics in breast cancer. 1 One report described a 34% incidence of central nervous system metastases in patients 2 6 treated with trastuzumab for breast cancer . More recently, the NEfERT-T clinical trial which compared administration of either neratinib or trastuzumab in conjunction with paclitaxel